Pinpointing novel targets for osteoarthritis: A comprehensive cross-omics integration analysis

Area of Science:

• Genetics
• Molecular Biology
• Pharmacology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease with current treatments focused on symptom management.
• Targeted therapies for OA are gaining attention, necessitating the identification of novel therapeutic targets.
• Multi-omics approaches offer innovative strategies for uncovering potential therapeutic targets in complex diseases like OA.

Purpose of the Study:

• To identify genetic markers and molecular pathways associated with Osteoarthritis (OA) using integrated multi-omics data.
• To explore potential drug candidates and therapeutic targets for OA through molecular docking and pathway analysis.
• To provide a comprehensive understanding of the molecular mechanisms underlying OA for novel therapeutic development.

Main Methods:

• Integrated multi-omics analyses including expression quantitative trait loci (eQTL), protein quantitative trait loci (pQTL), and methylation quantitative trait loci (mQTL).
• Summary-data-based Mendelian randomization and colocalization analyses to identify genetic associations.
• Single-cell sequencing, molecular docking, and USP8-centered protein-protein interaction (PPI) network analyses.

Main Results:

• Four key genes (USP8, DLK1, OMG, SNUPN) were identified as significantly associated with OA through multi-omics integration.
• USP8 showed strong multi-omics evidence linking it to OA, while DLK1, OMG, and SNUPN were also identified.
• Molecular docking predicted GDC-0134 as a potential drug targeting DLK1, and genetic associations were validated in a replication cohort.

Conclusions:

• Multi-omics integration successfully identified key genes and pathways implicated in OA pathogenesis.
• USP8 and DLK1 emerged as promising therapeutic targets for developing novel OA treatments.
• The study provides a foundation for developing targeted therapies to modify OA progression.